The Effects of Oral Altrenogest on Hormonal,Testicular, and Behavioral Profiles of Two-Year-Old Stallions

Altrenogest is frequently administered to young stallions in the equine industry as an off-label use to suppress sexual/aggressive behavior. In this study, 2-yr-old Quarter Horse stallions in early-performance training were administered altrenogest (0.044 mg/kg BW daily) to determine the effects on sexual/aggressive behavior, testicular parameters, and steroid hormone profiles. Horses were randomly assigned to treatment (n = 5) and control (n = 5) groups. The treatment group was administered a daily oral dose of 0.044 mg/kg BW daily for 67 d; the control group was given a daily oral sham dose of corn oil for 67 d. No significant differences were found between treatment groups in BW or body condition scores. Altrenogest had no effect on any behavioral parameters or seminal parameters measured. Averages of total scrotal width (TSW) were lower (P<0.03) for treatment animals at the end of treatment period (d 67). By d 157 mean TSW for both treatment and control stallions were not different. Both were significantly higher (P<0.03) than pretrial values at d 157. Comparisons of testicular weight (d 157) between control and treatment groups were not different. Histological analysis of testicular tissue revealed no significant difference for the average number of spermatids per seminiferous tubule. Altrenogest treatment reduced serum estrogen levels (estradiol 17-β) by d 67 (P<0.02); however, estrogen levels returned to pre-treatment values after a 90-d recovery. Serum testosterone values were not affected by treatment. Further research is needed to determine dose and age effects of altrenogest in the stallion.     

Growth, carcass traits, boar odor and testicular and endocrine functions of male pigs fed a progestogen, altrenogest

Crossbred (Chester White X Yorkshire X Duroc) boars were used to evaluate the effects of feeding a progestogen (altrenogest) on body growth, endocrine function (determined during feeding and after withdrawal of altrenogest), carcass composition, boar odor and testicular function (determined after a 30-d withdrawal from altrenogest). Boars from 18 litters were assigned at 12 wk of age to three treatments: 1) 18 control boars; 2) 18 boars fed altrenogest (20 mg/day) for 6 wk from 15 to 21 wk of age, followed by 30 d with no treatment; and 3) 18 boars castrated at 2 wk of age (barrows). Daily gains were greater (P less than .05) in boars fed altrenogest than in barrows through 21 wk of age but were lower (P less than .05) than those of control boars and barrows during the 30-d withdrawal period. Boars fed altrenogest weighed less (P less than .05) than control boars and barrows at 25 wk of age (at slaughter). Both groups of boars were similar in percentage of muscle and had less (P less than .05) backfat than barrows, whereas control boars had the largest (P less than .05) loineye areas. Based on evaluations by a trained sensory panel, intensity of boar odor in fat samples was similar for both groups of boars and was greater (P less than .05) than that for barrows. Weights of accessory reproductive glands and weight and sperm content of testes and epididymides were reduced (P less than .05) in boars fed altrenogest.(ABSTRACT TRUNCATED AT 250 WORDS)     

Growth Performance and Serum Prolactin Concentrations of Stocker Steers Implanted with Trenbolone Acetate While Grazing Endophyte-Infected Fescue in the Spring

A 64-d grazing study was conducted with a 2 × 2 factorial arrangement of treatments to evaluate the impact of implant treatment on growth performance, hair score, and serum prolactin levels of steers grazing tall fescue with high (HE) or low (LE) levels of infection with the endophytic fungus Neotyphodium coenophialum. Mixed-breed steers (n = 130; 246 ± 3.5 kg initial BW) were allocated randomly to one of three HE or one of four LE pastures beginning April 13. Within each replication, one-half of the steers were implanted (IMP) with trenbolone acetate (40 mg) and estradiol (8 mg), and one-half were not implanted (NI). No implant treatment × endophyte level interactions were detected (P>0.10). Steers grazing HE had lower (P<0.01) BW gain, inferior (P<0.05) hair scores, and lower (P<0.01) serum prolactin concentrations on d 64 than those steers grazing LE. Total BW gains were greater (P=0.01) from IMP steers than from NI steers, but serum prolactin concentrations and hair scores did not differ (P>0.10) between IMP and NI steers on either d 36 or 64. When tabulated across forage and implant treatments, correlations were negative between overall BW gains and hair scores measured on d 64 (r = 0.28; P<0.01), and positive between overall BW gains and serum prolactin levels measured on d 36 and 64 (r = 0.33 and 0.43, respectively; P<0.001). Therefore, fescue toxicity symptoms were manifested in HE steers, and implanting trenbolene acetate and estradiol improved grazing BW gain, but no endophyte level × implant interactions were detected.     

Body growth and testicular characteristics of boars fed a synthetic progestogen, altrenogest

A synthetic progestogen (altrenogest) was fed to 24 Yorkshire X Duroc boars to determine effects on body growth, serum testosterone, and testicular characteristics. Boars from six litters (blocks) were allotted randomly to one of four treatment groups at 12 wk of age. Treatment groups were: controls, altrenogest fed for 3 wk, altrenogest fed for 6 wk and altrenogest fed for 9 wk. Treatment began at 15 wk of age at a daily dose of 20 mg X boar-1. Although there were no differences among treatment groups for gain and feed intake, boars fed altrenogest for 6 and 9 wk tended to consume more feed and were less (P less than .05) efficient than boars fed altrenogest for 3 wk or controls. Boars fed altrenogest for 3, 6 and 9 wk maintained lower (P less than .05) peripheral serum testosterone concentrations than controls from 15 to 24 wk of age. However, serum testosterone increased after altrenogest withdrawal in the 3- and 6-wk treatment groups but did not reach control concentrations by 24 wk. Boars fed altrenogest for 9 wk maintained serum testosterone below 1 ng/ml during the treatment period. Despite lower concentrations of serum testosterone in altrenogest-treated boars, backfat thickness was similar to controls, perhaps suggesting a slight anabolic effect of altrenogest on nutrient partitioning. Testicular weights and volumes at 24 wk decreased (P less than .001) linearly with increased duration of altrenogest feeding. Serum testosterone and estradiol in testicular venous effluent at castration were lower (P less than .01) in altrenogest-treated boars than in controls. These data demonstrate that feeding altrenogest inhibits both testicular growth and steroidogenesis of boars without altering body growth or backfat thickness.     

Efficacy of short-term administration of altrenogest to postpone ovulation in mares

Estrogen from a growing follicle stimulates the preovulatory surge of luteinizing hormone (LH) while progesterone (P) is known to suppress LH. The possibility exists that administration of P, in the presence of an ovulatory follicle, would sufficiently suppress LH and, therefore, delay ovulation. The objective of this research was to elucidate the potential for oral administration of altrenogest (17-Allyl-17β-hydroxyestra-4,9,11-trien-3-one) to postpone ovulation of a preovulatory follicle (35 mm) for approximately two days. Fourteen light-horse mares, ranging in age from two to 19 years, were randomly assigned to one of three treatments (A-.044 mg/kg BW altrenogest for two days; B-.088 mg/kg BW altrenogest for two days; and C- no altrenogest). Mares began treatment when a 35-mm or greater follicle was observed via real-time transrectal ultrasonography. Both number of days until ovulation and follicular maintenance differed between treated and control mares. Number of days until ovulation was increased (P<.05) for mares in treatment A when compared with the control mares. Follicular diameter maintenance, a measurement of follicular diameter throughout treatment, also increased (P<.05) for mares in treatment A when compared with the control mares. Mean LH concentration was not different between mares treated with altrenogest at either treatment dose when compared with the control mares. Pregnancy rates and embryonic vesicle size change were also measured to determine potential effects of altrenogest administration. No differences (P>.05) were found in either characteristic.Short-term administration of altrenogest increased the number of days to ovulation. Further study is warranted to prove conclusively that altrenogest increases follicular maintenance, alters the preovulatory LH surge, and has no detrimental effects upon reproductive efficiency.     

Effect of zeranol or melengestrol acetate (MGA) on testicular and antler development and aggression in farmed fallow bucks

Fifteen yearling fallow bucks were randomly assigned by BW to one of three treatment groups: control (C; n = 5), melengestrol acetate (MGA; n = 5), and zeranol (Z; n = 5), to evaluate effects on testicular development, aggressive behavior, antler growth, sexual activity, ADG, and BW. Zeranol-treated bucks received zeranol ear implants (36 mg) at 90-d intervals, and MGA-treated bucks received MGA in the ration (100 microg x animal(-1) x d(-1)). Bucks grazed ryegrass/Coastal bermudagrass pasture and were supplemented with 3:1 corn/soybean meal at 0.45 kg x animal(-1) x d(-1). Body weights, body condition scores (BCS), blood samples, and testis measurements were obtained at d 0 and at 14-d intervals for 229 d. As bucks reached hard antler (7/15 to 8/25), antlers were harvested and weighed, and ejaculates were collected at 14-d intervals. Aggression was evaluated using 10-min video sessions scoring body blows, avoidance, head pushes, and head bunts. Scrotal circumference (SC) and paired testis volume were affected by a day x treatment interaction (P < 0.01); testes of zeranol-treated bucks were smaller than those of control or MGA-treated bucks. First sperm in the ejaculate tended to be delayed (P < 0.10) in zeranol-treated bucks compared with control and MGA-treated bucks. Melengestrol acetate-treated bucks had a maximum sperm concentration in the ejaculate that was three times (P < 0.05) that of control bucks and nine times (P < 0.05) that of zeranol-treated bucks. Antler weight was the least (P < 0.01) for bucks receiving zeranol and greatest (P < 0.10) for MGA-treated bucks; intermediate values were recorded for the control bucks. Aggressive behavior was delayed (P < 0.05) for zeranol-treated bucks until treatment effects were overcome. Melengestrol acetate-treated bucks had decreased (P < 0.01) aggressive behavior compared with control bucks. Melengestrol acetate-treated bucks had increased (P < 0.05) serum testosterone concentrations compared with control and zeranol-treated bucks. Human chorionic gonadotropin-stimulated peak serum testosterone concentrations for zeranol-treated bucks were delayed (P < 0.01) compared with control and MGA-treated bucks. Although zeranol-treated bucks overcame treatment effects, they were never able to reach testicular measurements or sperm concentrations equal to those of the control or MGA-treated bucks. Zeranol and MGA treatments may have both positive and negative effects that can be utilized when producing slaughter bucks.     

Recommendations for clinical GnRH challenge testing of stallions

Eight mature light-breed stallions with normal testes size, sperm output and semen quality were used to evaluate response to 3 GnRH challenge regimens in the summer in southeast Texas. Gonadotropin releasing hormone (50 μg) was administered intravenously once to each of eight stallions after three days of sexual rest (50 μg GnRH-1X). The same stallions were administered either 5μg GnRH intravenously once hourly for three injections (5 μg GnRH-3X) and 15μg GnRH intravenously once (15μg GnRH-1X) one and two weeks later. Blood samples were collected prior to and at intervals after GnRH administration. Plasma was immediately separated from blood samples and was frozen until assayed for LH, FSH, estradiol and testosterone concentrations. Percentage changes in hormone concentrations from pre-treatment values (baseline) were analyzed by paired studient'st-test to detect significant rises in hormone concentrations. Group mean percentage changes in hormone concentrations were analyzed by analysis of variance to compare responses among treatments. A computerized peak-detection algorithm (PC Pulsar) was used to detect peaks in LH and testosterone concentrations following 5 μg GnRH-3X and 15 μg GnRH-1X treatment.No differences (P>0.10) were detected in percentage change from baseline concentration for LH, FSH, or testosterone at one or two hours after administration of any of the three regimens of GnRH. When more frequent sampling intervals were analyzed for 5 μg GnRH-3X or 15 μg GnRH-1X treatments, no differences were detected in percentage change from baseline concentration for any hormone at 15, 30 or 60 minutes. Thereafter, percentage changes in concentrations of LH and FSH remained increased for 5μg GnRH-3X compared to 15 μg GnRH-1X treated stallions (P<0.05). Percentage changes in concentrations of testosterone were increased for 5μg GnRH-3X compared to 15 μg GnRH-1X treated stallions from 180–300 min (P<0.05), while no differences (P>0.10) were detected between 5 μg GnRH-3X and 15 μg GnRH-1X treated stallions for changes in concentrations of estradiol throughout the experiment.For 15 μg GnRH-1X treated stallions, maximum concentrations of LH in PC Pulsar-detected peaks occurred most commonly at 15 to 30 minutes (7/8 treatment periods) after GnRH injection. Maximum concentrations of testosterone in PC Pulsar-detected peaks occurred most commonly at 60–120 min (7/8 treatment periods) after GnRH injection.A protocol of blood sampling prior to, and 15, 30, 60 and 120 minutes after, intravenous administration of small doses of GnRH would be practical for challenge testing of stallions during the breeding season. In order to reduce cost of hormone assays, we suggest assay of the pre-challenge blood sample (baseline) could include LH, FSH, testosterone and estradiol concentrations (to assess overall hypothalamic-pituitary-testicularfunction), while only LH and testosterone concentrations need be determined after GnRH administration (to assess pituitary and testicular responsiveness). Assay for LH could be done on only the 15 and 30 minute post-GnRH samples, and assay for testosterone could be done on only the 60 and 120 minute post-GnRH samples. Failure to achieve approximately a 50% increase in LH concentration by 30 minutes after GnRH administration, and/or failure to achieve approximately a 100% increase in testosterone concentration by two hours after GnRH administration, could be further pursued either by treatment with increasing dosages of GnRH, or repeated administration of GnRH at hourly intervals, as has been suggested by other workers.     

Semen parameters and hormone concentrations in stallions subjected to long-term estrogen administration

Eight pony stallions were paired by estimated daily sperm output (DSO) and randomly assigned to one of two treatments in a randomized block experiment. Stallions received 44 μg/kg BW estradiol cypionate (ECP) or an equivalent volume of physiological saline solution on alternate days during the breeding season. Blood samples collected immediately preceding each injection were assayed for luteinizing hormone (LH), estradiol-17β (E₂) and testosterone (T). Semen was collected twice weekly, 3.5 days apart, to evaluate sperm motility and total number of sperm per ejaculate. Prior to and after 4, 8 and 12 weeks on treatment, semen was collected once daily for 7 days to determine DSO. Data were separated into 9 periods (10 days each) for statistical analysis and subjected to analysis of variance for a randomized block design to determine treatment effects.There were no differences (p>.05) between groups for DSO or LH prior to initiation of treatment. Testosterone was higher (p<.05) in ECP stallions compared with C stallions prior to treatment and at all time points measured. As expected, E₂ was higher (p<.05) in the ECP stallions compared to C stallions after 20 days (period 2) of treatment and for the remainder of the experiment. However, E₂ was higher (p<.05) in the C group prior to treatment, but there was no difference between the groups after 10 d of treatment (period 1). ECP stallions had higher (p<.05) DSO than C stallions after 30 d on treatment. After 40 and 50 d (periods 4 and 5), ECP stallions demonstrated higher (p<.05) total sperm per period than C stallions. This was preceded by higher (p<.05) LH values for ECP stallions than for C stallions after 10 and 20 d (periods 1 and 2). No differences were found between the ECP and C groups for LH between 30 and 60 d. Although numerically higher, no significant differences (p>.05) were seen after 60 days for DSO or after 60, 70 or 80 days for total sperm per period. ECP stallions had higher (p<.05) DSO and total sperm per period after 90 d than C stallions. Additionally, LH remained significantly higher (p<.05) in the ECP group after 60 days (periods 7, 8 and 9). Elevated LH concentrations in ECP stallions demonstrated that estrogen treatment did not inhibit LH secretion in this study.     

Effects of Feed Intake Restriction on Performance and Carcass Characteristics of Finishing Beef Steers,

Crossbred steers (n = 264, 311 ± 1.6 kg initial BW) were blocked by BW, randomly assigned to one of four treatments (28 pens, 7 pens per treatment), and fed a common 90% concentrate diet to determine the effects of the severity of caloric restriction on animal performance and carcass characteristics. Treatments were 1) ad libitum access to feed for 151 d (AL100); 2) 75% of DMI by AL100 for 65 d, 95% of DMI by AL100 for 65 d, and ad libitum access to feed for 21 d (AL85); 3) 80% of DMI by AL100 for 65 d, 100% of DMI by AL100 for 65 d, and ad libitum access to feed for 21 d (AL90); and 4) 85% of DMI by AL100 for 65 d, 105% of DMI by AL100 for 65 d, and ad libitum access to feed for 21 d (AL95). Feed was offered for AL85, AL90, and AL95 based on DMI by AL100 the previous week. All steers were fed a similar quantity of DM for 4 d prior to initial, interim, and final BW determinations to minimize gastrointestinal fill differences. Overall DMI was greater (P<0.01) for AL100 than for the average of the remaining treatments and decreased linearly (P<0.01) among AL95, AL90, and AL85. Overall ADG (carcass-adjusted) was less (P<0.01) for AL85, AL90, and AL95 than for AL100, whereas overall ADG:DMI (carcass-adjusted) did not differ (P>0.10) between AL100 and the average of the remaining treatments. Overall ADG and ADG:DMI (carcass-adjusted) responded quadratically (P<0.05) with increasing DMI restriction. Hot carcass weight, longissimus area, and kidney, pelvic, and heart fat percentage were greater (P<0.05) for AL100 than for the remaining treatments and responded quadratically (P<0.10) among AL85, AL90, and AL95. Marbling score was greater (P<0.10) for AL100 than for the average of the remaining treatments, and the number of carcasses grading Prime + Choice tended to be higher (P<0.15) for AL100 and AL95. Restricting feed intake of finishing yearling steers to an average of 85 to 95% of ad libitum for 130 d of a 151-d feeding period generally resulted in slower ADG, lesser marbling scores, and carcasses that were lighter and leaner compared with yearling steers allowed ad libitum to feed and harvested after an equal number of days on feed.     

Reproductive response of mares after treatment with progestogens with and without the additional of estradiol

A study involving 60 light-horse mares was conducted both to evaluate the response of mares to injectable progester- one or altrenogest and to determine ifestradiol in combination with either progestogen provided any added benefit. Treatments were initiated at either early estrus, late estrus, early diestrus, mid-diestrus or late diestrus in order to assess the effect of stage of cycle at onset of treatment. Within each of these stages of the cycle, mares were randomly assigned to 1 of 4 treatments: 150 mg progesterone injected i.m. (P); 150 mg progesterone + 10 mg estradio11713 injected i.m. (P+); .044 mg altrenogest per kg body weight orally (A); and .044 mg per kg body weight orally plus 10 mg estradiol 1713 i.m. (A+). All treatments were given daily for 7 days with 10 mg PGFaCt given on day 7 to all mares. The number of mares ovulating by day 14 after treatment (N=15/group) was 13, 7,11 and 8 forA, A+, P and P+, respectively. The response of mares to progesterone and altrenogest was similar. Fewer (Pì0.05) mares given combined steroid treatments ovulated within 14 days (15 of 30) than those given progestogen treatments. Stage of cycle had no affect (Pì0.05) on response of mares ovulating within 14 days or after 14 days of treatment. Mares that ovulated within 14 days of treatment had larger foUieles after progestogen treatment than those not ovulating by 14 days.     

Safety of altrenogest in pregnant mares and on health and development of offspring

Fifty-one light-horse mares were utilized to evaluate the safety of an oral progestin, altrenogest, administered throughout gestation on: gestation length, embryonic and fetal loss, periparturient events, health and development of offspring, and future reproductive capabilities of the mares. Pregnancies were established by inseminating mares with 250 × 10⁶ progressively motile spermatozoa from the same stallion every other day throughout estrus or by non-surgical transfer of embryos. Mares were randomly assigned to 1 of 2 treatments upon confirmation of pregnancy on day 20: 1) controls, 2 ml of neobee oil orally per 44.5 kg of body weight; and 2) treated, 2 ml of altrenogest dissolved in neobee oil at a concentration of 2.2 mg/ml orally per 44.5 kg of body weight. Treatments were administered daily from day 20 to 320 of gestation.There were no significant differences between treatment groups for duration of gestation, placental weight, time to placental expulsion and incidence of retained placental membranes. Number of female foals born from altrenogest treated mares (14 of 23) was greater (P<.05) than the number from untreated control mares (4 of 16). Female foals born from altrenogest treated mares had larger clitori (P<.05) than those from control mares. Times to sternal recumbency, standing and nursing were similar for the 2 groups (P>.05). Body weight and height at withers, heart girth circumference and length and width of cannon were measured at time of birth and at 2, 4, 6, 8, 12 and 16 weeks of age. Measurements did not differ (P>05) between treated and control foals for any development parameters.Beginning on day 20 postpartum, mares were teased daily. During estrus, mares were inseminated every other day with 250 × 10⁶ motile spermatozoa. Teasing and/or insemination was continued for 2 cycles or until mares were 35 days pregnant. The number of mares pregnant after 1 cycle and after 2 cycles of insemination was similar (P>.05) for treated and control mares. Nineteen of 21 treated mares and 15 of 16 control mares were pregnant after 2 cycles of insemination. Number of cycles per pregnancy was similar (P>.05) for treated and control mares (1.37 vs 1.13) as was number of days mares exhibited estrus (6.30 vs 6.13). Number of inseminations per cycle did not differ (P>.05) between treated and control mares (2.92 vs 3.00). In summary, there was no effect of treatment with altrenogest from day 20 to 320 of gestation on periparturient events, viability and growth of offspring and subsequent reproductive performance of mares.     

Effect of altrenogest‐treatment of mares in late gestation on adrenocortical function,blood count and plasma electrolytes in their foals

Reasons for performing study: Mares with compromised pregnancies are often treated with altrenogest to prevent abortion. However, there is only limited information about effects on the foal when altrenogest treatment is continued during final maturation of the fetus. Objectives: To determine effects of altrenogest treatment during late gestation in mares on maturity, haematology changes, adrenocortical function and serum electrolytes in their newborn foals. Methods: Six mares were treated with altrenogest (0.088 mg/kg bwt) once daily from Day 280 of pregnancy until foaling and 7 mares served as controls. Results: Foals born to altrenogest‐treated mares had a significantly lower neutrophil/lymphocyte ratio on the first day after birth than control foals (P<0.05). Basal plasma cortisol concentrations immediately after birth were higher in foals of altrenogest‐treated mares than in control foals (P<0.05). Cortisol release in response to exogenous adrenocorticotropic hormone (ACTH) ‐ except for higher values 15 min after ACTH injection in foals of altrenogest‐treated mares on Day 1 ‐ revealed no differences in adrenocortical function between the groups of foals. Plasma potassium concentration in foals from altrenogest‐treated mares compared to control foals was significantly lower immediately after birth (P<0.05) and plasma ionised calcium concentration was significantly lower 3 h after birth (P = 0.01). Conclusions and potential relevance: Altrenogest treatment of pregnant mares prolonged labour had no major effects on adrenocortical function in foals. A reduced neutrophil/ lymphocyte ratio in these foals may suggest either immunomodulatory effects of altrenogest or dysmaturity of the foals.     

Efficacy of altrenogest administration to postpone ovulation and subsequent fertility in mares

A recent report suggested administration of altrenogest during the follicular phase could postpone ovulation. Based on these results, two questions were generated. We first hypothesized that by initiating a altrenogest treatment earlier in the estrous cycle, a greater and/or more consistent delay in ovulation would result. Second, we hypothesized that exposure to elevated progestin concentrations might alter viability of the ovulatory follicle and oocyte. The focus of the first experiment was to determine if initiation of altrenogest treatment at different stages of the estrous cycle would yield a more predictable time to ovulation, whereas the second experiment was designed to determine whether mares receiving altrenogest during estrus had compromised fertility. In the first experiment thirty mares of mixed light breed, ranging in age from 5-15 years, were randomly assigned to one of three groups. The two treated groups received altrenogest (0.088 mg/kg of body weight) for two days once a follicle of 30 or 35 mm in diameter was detected. Control mares were not treated. Mares treated with altrenogest whether initiated at the detection of a 30 or 35 mm follicle demonstrated similar (P>.05) day to ovulation interval when adjusted to 35 mm (5.4 and 5.6 days, respectively). Both treated groups demonstrated a delayed interval (P<.05) when compared to control (3.9 days). Thirty-six mares of similar breed and age, were randomly assigned to two groups for use in the second experiment. All mares were monitored daily via transrectal ultrasonography from the time a 35 mm or greater follicle was detected until ovulation. Treated mares received daily doses of altrenogest (0.088 mg/kg of body weight) for two days once a follicle of 35 mm or greater was detected. Control mares received no treatment. Fertility data were collected from mares inseminated every other day with 500 million motile spermatozoa from one of two stallions with proven fertility. Pregnancy data were collected via transrectal ultrasonography at days 12, 14 and 16 post-ovulation. Ovulation data were collected from 27 control cycles and 26 treated cycles. Contrary to previous reports and Experiment 1, no difference (P=0.35) was noted between groups with respect to days to ovulation. Control mares averaged 4.14 days and treated mares averaged 4.7 days to ovulation from initial detection of a 35 mm follicle. Fertility data were also similar (P=0.8) between control and treated mares (66.6% and 61.5% per cycle, respectively). Interestingly, a greater number (P=0.017) of treated cycles (5/26) resulted in follicular regression than did control cycles (0/27). While these data suggest that this dosage of altrenogest may not postpone ovulation, it did appear related to increased incidence of follicular regression. Fertility was unaffected, however, in those mares that ovulated. Further studies are needed in which initiation at different stages of estrus and different doses of altrenogest are used.     

Effects of Fishmeal Supplementation on Fertility and Plasma Ω-3 Fatty Acid Profiles in Primiparous,Lactating Beef Cows

A 2-yr study was conducted using 82 lactating, 2-yr-old, primiparous crossbred beef cows (yr 1, n = 40; yr 2, n = 42) to study the effect of fishmeal supplementation on reproductive performance. Cows were fed a corn silage-based diet supplemented with fishmeal (5% DM) or corn gluten meal (8.7% DM), beginning 25 d prior to the start of and continuing through the 90-d breeding season. Cows were artificially bred with semen from bulls of proven fertility 12 h after being detected in estrus. Jugular blood samples were taken from all cows on d 3 or 4, 9 or 10, and 15 or 16 following first insemination and analyzed for serum progesterone. During yr 2 of the study, additional blood samples were collected from four cows within each treatment group immediately before supplementation began (d 0) and at 7-d intervals for the first 35 d of supplementation. Plasma samples were analyzed for Ω-3 fatty acids. Serum progesterone concentrations did not differ between treatment groups following the first insemination (P>0.76). However, first service conception rates approached significance (NS; P=0.12) and tended to be greater for cows supplemented with fishmeal when compared with cows supplemented with corn gluten meal (76% vs 62%, respectively). Overall pregnancy rates at the end of the breeding season did not differ between the two treatment groups (P>0.64). In yr 2, within 7 d of supplementation, plasma eicosapentaenoate (EPA) and docosahexaenoate (DHA) were greater for cows supplemented with fishmeal (P<0.001). In conclusion, these data indicate that fishmeal supplementation alters plasma EPA and DHA (yr 2) and may improve first service conception rates in primiparous beef cows.     

Effects of age,season, and fertility status on plasma and intratesticular immunoreactive (IR) inhibin concentrations in stallions

The nature of the relationship between inhibin and reproductive function in the stallion is yet to be elucidated. Blood and testes from 51 light horse stallions ranging in age from 2 mo to 25 years were collected during the breeding and nonbreeding seasons to study the effects of testicular maturation, aging, season, and fertility status on peripheral and intratesticular concentrations of Ir inhibin and other reproductive hormones. Of the 51 stallions, 12 age-matched stallions (6 fertile, 3 subfertile, and 3 infertile) were used in the fertility study. Blood samples were taken before castration and plasma stored at −20°C for analysis of Ir inhibin, luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), estradiol (E₂), and estrogen conjugates (EC) by radioimmunoassay (RIA). Testes were homogenized and testicular extracts prepared and frozen at −70°C for analysis of Ir inhibin, T, E₂, and EC by RIA. Plasma concentrations of Ir inhibin, LH, FSH, T, E₂, and EC and intratesticular concentrations of Ir inhibin, T, E₂, and EC increased with age (P < 0.01). The most dramatic effect appeared to be during testicular maturation. An aging effect was not observed in adult stallions. A seasonal effect was not detected for any of the plasma hormones, whereas for the intratesticular hormones the only change noted was an increase in T in the nonbreeding season (P < 0.05). Plasma Ir inhibin, E₂, and EC were lower (P < 0.01) and gonadotropins higher (P < 0.05) in infertile stallions. Plasma T levels did not change. Intratesticular Ir inhibin concentrations tended to be lower (P < 0.1) in subfertile stallions and significantly lower (P < 0.01) in infertile stallions, whereas intratesticular steroid levels were not different among the three groups. In conclusion, plasma and intratesticular Ir inhibin concentrations seem to be affected by testicular maturation and fertility status.     

Supplementation with Whole Sunflower Seeds Before Artificial Insemination in Beef Heifers

The objective of this study was to evaluate synchronization and pregnancy rates of beef heifers supplemented with 0.91 kg of whole sunflower seeds for 0, 30, or 60 d before AI. Beef heifers from four locations (n = 1,014) were assigned by BW to treatment (within location) and randomly to AI sire. Heifers at Location 1 (n = 176; mean BW = 332 kg) received either 0- or 60-d sunflower seed treatments. Heifers at Location 2 (n = 397; mean BW = 334 kg) were fed sunflower seeds for 0, 30, or 60 d. Heifers at Locations 3 (n = 211; mean BW = 345 kg) and 4 (n = 230; mean BW = 343 kg) received 0- or 30-d sunflower seed treatments. Within location, diets were formulated to be isocaloric and isonitrogenous. All heifers received melengesterol acetate (0.5 mg/d per head) for 14 d followed 19 d later by an injection of prostaglandin F_2a (PGF) (25 mg). Heifers were bred by AI according to the AM/PM rule except on d 3 when all heifers that had not exhibited estrus were artificially inseminated in mass. Neither 72-h estrous response nor pregnancy rate was affected (P>0.10) by 30- or 60-d sunflower feeding. In summary, feeding 0.91 kg of whole sunflower seeds for either 30 or 60 d before AI did not improve estrous response or pregnancy rate when compared with controls.     

Effect of blocking vision and olfaction on sexual responses of haltered or loose stallions

Ten stallions were used in a modified split-plot design involving four treatments and two handling methods. Treatments were: a) vision and olfaction not blocked; b) vision blocked, olfaction not blocked; c) vision not blocked, olfaction blocked; and d) vision and olfaction blocked. The methods of handling were: a) stallions turned loose in teasing area, and b) stallions handled on a lead shank. Stallions teased four estrous mares, four diestrous mares and four geldings. Criteria for evaluation of stallion behavior was duration of investigation (sec), of area as well as various portions of the stimulus animal's anatomy, and other pre-copulatory sexual behaviors (Table 1) in duration and frequency. Except for area investigation and no investigation, there were more frequent or longer responses when vision was not blocked compared to blocked (P<0.05). Events associated with display of flehmen and mounting activity were lower (P<0.05) when vision was blocked. Handling a stallion on a lead shank, while teasing, resulted in 23 longer or more frequent pre-copulatory sexual behaviors than when the stallions were loose. There were more frequent or longer (P<0.05) behavioral responses when stallions were handled on a lead shank and olfaction was not blocked. Events such as duration and number of flehmen responses were lower (P<0.05), and time of no investigation was longer (P<0.001) when olfaction was blocked. There was no difference (P>0.05) in the time spent inyestigating estrous mares, diestrous mares or geldings, except for number of flehmen responses. Number of flehmen responses to estrous mares was higher (P<0.05) than to diestrous mares, while number of flehmen responses to diestrous mares was higher (P<0.001) than to geldings. Blocking olfaction did not decrease frequency or duration of sexual behaviors as much as blocking vision (P<0.05), resulted in decreased (P<0.05) flehmen responses. Blocking vision significantly decreased (P<0.05) teasing behaviors, duration of erection, flehmen, and number of mounts regardless of stimulus animal. Stallions utilized visual stimuli to a greater extent than olfactory stimuli. Handling stallions on a lead shank appeared to enhance expression of precopulatory behavior compared to when the stallions were loose.     

Comparison of Swine Diets Containing a Food Waste Product Made with Wheat Middlings and Corn or a Corn/Soybean Diet,

Although pigs will readily consume wet food waste (FW), the high moisture content contributes to spoilage and feeding management problems. The use of a dry, processed FW product was compared with a traditional corn and soybean (CS) diet using growing swine in two performance trials and one digestibility trial. The FW diet contained approximately 20% processed FW (DM basis). In Trial 1, 24 gilts (76.4 kg) housed in eight replicated pens (four pens per treatment) were fed in a 6-wk trial. Intake, BW gain, feed efficiency, and carcass characteristics were compared. Feed intake and BW gain averaged 3.4 and 3.6 kg of DM/d and 0.87 and 0.85 kg/d for gilts fed traditional and FW diets, respectively. There were no differences in these or any other measurements (P>0.05). In Trial 2, 12 barrows (84.3 kg) housed in four replicated pens (two pens per treatment) were fed in a 6-wk trial. Intake, BW gain, feed efficiency, and carcass characteristics were compared. Feed intake and BW gain averaged 3.1 and 3.3 kg of DM/d and 0.62 and 0.71 kg/d for barrows fed traditional and FW diets, respectively. Four growing gilts (68.2 kg) were used to compare digestibility in a crossover design. There were no differences (P>0.10) for DM, CP, ADF, or NDF digestibility when feed intake averaged 1.9 kg of DM/d for both FW and CS diets. The use of up to 20% processed FW may be suitable in commercial swine diets.     

Performance and Nutrient Utilization of Steers Consuming Broiler Litter with or without Aluminum Sulfate

The objective of this study was to determine the effects of adding alum (aluminum sulfate) to broiler litter on nutrient digestibility and utilization and animal BW gains when fed to steers. To determine nutrient digestibility and utilization, 12 steers were housed in individual metabolism crates and fed one of three diets: 1) 1:1 corn:broiler litter treated with alum (ALUM); 2) 1:1 corn:untreated traditional broiler litter (TRAD); 3) a commercially available diet (CON). Dry matter intake did not differ (P>0.05) among treatments. Digestibility of DM and OM was greater (P<0.05) in steers fed ALUM and TRAD, than in steers fed CON. NDF was most digestible (P<0.05) by animals fed TRAD and least digestible by those fed CON, with those consuming ALUM being intermediate. No differences (P>0.05) were observed in ADF, CP, or energy digestibility. Apparent protein retention was greater (P<0.05) in steers fed ALUM and TRAD than in those fed CON. To determine the effect of broiler litter on steer BW gains, a 28-d grazing trial was conducted with 20 steers randomly allotted to the same two broiler litter dietary treatments (n=10) used in the digestibility trial. Steers receiving ALUM gained faster (P<0.05) than those receiving TRAD. Addition of aluminum sulfate to broiler litter fed to cattle did not inhibit nutrient digestibility or utilization.     

Acute and Chronic Effects of a Contraceptive Compound RTI‐4587‐073(l) on Testicular Histology and Endocrine Function in Miniature Horse Stallions

The objective of this study was to evaluate acute endocrine effects as well as histological changes in testicular parenchyma induced by the contraceptive compound RTI‐4587‐073(l). Six miniature stallions were used in this experiment. The treatment group (n = 3) received one oral dose of 12.5 mg/kg of RTI‐4587‐073(l), and the control group (n = 3) received placebo only. The stallions' baseline parameters (semen, testicular dimensions, endocrine values) were collected and recorded for 5 weeks before treatment and for 6 weeks after treatment. Multiple blood samples were collected for endocrine analysis. Testicular biopsies were obtained before treatment, 1 day after treatment and every other week after treatment. Ultrasound exams were performed to monitor the dimensions of the stallions' testes. All stallions were castrated 6 weeks after treatment. Sperm numbers, motility and percentage of morphologically normal sperm decreased (p < 0.05), while the number of immature germ cells increased in ejaculates from treated animals (p < 0.05). Serum concentrations of inhibin and follicle‐stimulating hormone did not change. Testosterone concentrations initially transiently decreased (p < 0.05) after administration of RTI‐4587‐073(l), and increased several days later (p < 0.05). Testicular content of testosterone and estradiol 17‐β was lower in treated stallions than in control stallions on Day 1 after treatment (p < 0.05). Severe disorganization of the seminiferous tubules, significant loss of immature germ cells and complete depletion of elongated spermatids were observed in testicular biopsies obtained from treated stallions 1 day, 2 and 4 weeks after treatment. These changes were still present in the testicular samples taken from treated stallions after castration. The results of this study confirmed that RTI‐4587‐073(l) has antispermatogenic effects in stallions. Furthermore, we concluded that this compound causes acute sloughing of immature germ cells from the seminiferous tubules. RTI‐4587‐073(l) has significant but transient effects on Leydig cell function in stallions.